NAD+ Therapy: Benefits, Evidence, and What to Know Before Trying It

The Hype Is Real. The Evidence Is Complicated.

NAD+ (nicotinamide adenine dinucleotide) has become one of the hottest molecules in anti-aging and longevity medicine. IV NAD+ clinics are everywhere. Supplement companies sell NMN and NR (NAD+ precursors) with promises of reversed aging, unlimited energy, and cellular rejuvenation.

Some of this is backed by legitimate science. Some of it is premature extrapolation from animal studies. And some of it is pure marketing. Let me sort through it.

What NAD+ Actually Does

NAD+ is a coenzyme present in every cell of your body. It is essential for:

Energy Production

NAD+ is a critical player in mitochondrial function. It shuttles electrons in the electron transport chain — the process that converts food into ATP (cellular energy). Without adequate NAD+, your mitochondria produce less energy. You feel it as fatigue.

DNA Repair

Enzymes called PARPs (poly-ADP-ribose polymerases) use NAD+ to repair damaged DNA. As we age, DNA damage accumulates and PARP activity increases, consuming more NAD+. This creates a vicious cycle: more damage, less NAD+ available for other functions.

Sirtuin Activation

Sirtuins (SIRT1-7) are proteins that regulate aging-related pathways: inflammation, metabolism, stress resistance, and gene expression. They require NAD+ to function. When NAD+ drops, sirtuin activity drops, and aging-related dysfunction accelerates.

Circadian Rhythm Regulation

NAD+ levels naturally oscillate over a 24-hour cycle, influencing sleep-wake patterns and metabolic timing.

What Happens to NAD+ With Age

NAD+ levels decline approximately 50% between ages 40 and 60. This decline correlates with:

• Decreased energy and exercise capacity
• Increased inflammation
• Impaired DNA repair
• Metabolic dysfunction
• Cognitive decline
• Weakened immune function

This decline is well-documented in human studies. It is arguably one of the most consistent biomarkers of biological aging.

The Evidence For Supplementation

What Animal Studies Show (Promising)

In mice, NAD+ boosting through NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside):

• Improved exercise endurance by 50-80%
• Reversed age-related vascular dysfunction
• Improved cognitive function in aged animals
• Extended lifespan in some models
• Improved insulin sensitivity and metabolic function
• Protected against neurodegeneration

These are dramatic results. They are also in mice.

What Human Studies Show (More Modest)

Human clinical trials of NAD+ precursors (NR and NMN) have shown:

• NAD+ levels do increase. Oral NMN (250-1200mg) and NR (300-1000mg) reliably raise blood NAD+ levels in humans.
• Some improvement in muscle function and exercise capacity in older adults (particularly NMN studies from Japan)
• Modest improvements in insulin sensitivity in some populations
• Improved sleep quality in some studies
• Generally well-tolerated with minimal side effects

What human studies have NOT yet shown convincingly:

• Lifespan extension (we cannot study this directly — humans live too long)
• Dramatic energy improvements in healthy younger adults
• Reversal of specific age-related diseases
• Cognitive enhancement in non-impaired individuals

IV NAD+ vs Oral Supplements

IV NAD+ Infusions

• Bypass gut metabolism entirely
• Achieve very high blood levels rapidly
• Sessions last 2-6 hours (can cause flushing, chest tightness, nausea if infused too quickly)
• Expensive ($500-1500 per session, typically series of 3-6)
• No evidence that IV delivery is necessary or superior to oral for long-term benefit
• Acute subjective effects (energy, clarity) reported by many patients — though placebo is hard to exclude

Oral Precursors (NMN, NR)

• Convenient and much less expensive
• Reliably raise NAD+ levels in studies
• NMN may have slightly better bioavailability than NR (though both work)
• Typical doses: NMN 500-1000mg daily, NR 300-600mg daily
• Effects take days to weeks to manifest

Which Is Better?

There is no high-quality evidence that IV NAD+ produces meaningfully different long-term outcomes than consistent oral supplementation. The IV route provides a dramatic experience — patients often feel something acutely — but whether that translates to sustained biological benefit beyond what oral supplementation provides is unknown.

Who Might Benefit Most

Based on the mechanism of action and available evidence, NAD+ supplementation is most rational for:

• Adults over 40 with age-related fatigue and declining exercise capacity
• People with metabolic dysfunction (insulin resistance, prediabetes)
• Those recovering from addiction (there is some evidence for NAD+ in withdrawal management, though it is limited)
• Athletes seeking recovery optimization
• People with neurodegenerative concerns (early/limited evidence)
• Individuals with documented DNA repair pathway insufficiency

Who Should Be Cautious

• Active cancer patients — NAD+ fuels cellular growth. Theoretically, it could fuel tumor growth. This is not proven but warrants caution.
• People on certain medications — NR/NMN can interact with medications metabolized through similar pathways
• Pregnant or breastfeeding women — insufficient safety data
• People expecting miracle results — NAD+ is a piece of the longevity puzzle, not the entire solution

My Honest Take

The biology is compelling. NAD+ decline is real, documented, and correlated with aging. Replacing it makes mechanistic sense. Animal data is exciting. Human data is encouraging but not yet transformative.

I think NAD+ supplementation (oral NMN or NR) is reasonable for adults over 40 as part of a comprehensive longevity approach — alongside exercise, sleep optimization, nutritional quality, and stress management. It is not a replacement for those fundamentals.

IV NAD+ is a legitimate option for patients who want acute effects or a kickstart, but I would not recommend it as ongoing monotherapy when oral supplementation is simpler, cheaper, and similarly effective for chronic use.

At Coral, we incorporate NAD+ and other longevity-focused interventions into comprehensive treatment plans. [Start your visit](/start) if you want to explore evidence-based approaches to aging well.